Taxoprexin Treatment for Advanced Skin Melanoma

Clinical trial NCT00249262 · COMPLETED

Trial details

NCT number: NCT00249262
Sponsor: American Regent, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2005-10-01
Primary completion: 2007-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.